Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |